Xeris Pharmaceuticals Investors

25 investors on Angel Roster list Xeris Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Xeris Pharmaceuticals can appear together.

Investors listed
25
With verified email
40%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 25 Xeris Pharmaceuticals investors

The most complete profiles first. Showing 25 of 25.

  • Adam GreeneVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Narendra NayakVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Nicholas BishopVerified

    Hedge Fund, Venture Capital, Investment Partner · United States

    Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information Services

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Craig HarrisVerified

    Angel Group · United States

    Health CareE-commerceBankingIdentity Management

    Portfolio: HUVRData, Boomerang Pies, Xeris Pharmaceuticals, SignUp.com and 10 more

    Verified email available

  • David BeierVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Verified email available

  • David HickmanVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Debbie BakerVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Howie FurstVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Josh FriedmanVerified

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Verified email available

  • Kevin BergVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Contact details available

  • Rob FaulknerVerified

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Vincent MelletVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • James Flynn

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information Services

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more

    Contact details available

  • Adam Soller

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Avi Kometz

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Contact details available

  • Christopher Herr

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Dayton Misfeldt

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Fred Craves

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Gerard van Hamel Platerink

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Hans Houser

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Killu Sanborn

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • Matt Kronmiller

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Tim Bernier, CFA

    Private Equity Firm · United States

    Health CareHospitalsConsumer GoodsInformation Technology (IT)

    Portfolio: Bi02 Medical, Epic Healthcare Staffing, Cardiac Dimensions, Syros Pharmaceuticals and 88 more

    Contact details available

  • carl goldfischer

    Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Dermira, Phenomix, NuPathe, Cydan and 52 more

    Contact details available

  • Daniel Fero

    Venture Capital, Investor · United States

    Series ABiotechnology

    Portfolio: Xeris Pharmaceuticals, 1859

    Contact details available

Frequently asked questions

How many Xeris Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 25 Xeris Pharmaceuticals investors. 10 of them (40%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (12), Private Equity Firms (10) and Hedge Funds (10). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Xeris Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Series B (4) and Series A (1).

Where are Xeris Pharmaceuticals investors based?

Most are based in the United States (25).

Which companies have Xeris Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Syros Pharmaceuticals (18), Conventus Orthopaedics (16), Auspex Pharmaceuticals (16), CymaBay Therapeutics (13) and Nuvation Bio (10).

How do I contact Xeris Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.